Back to Search
Start Over
Inhibition of late sodium current suppresses calcium-related ventricular arrhythmias by reducing the phosphorylation of CaMK-II and sodium channel expressions.
- Source :
-
Scientific reports [Sci Rep] 2017 Apr 20; Vol. 7 (1), pp. 981. Date of Electronic Publication: 2017 Apr 20. - Publication Year :
- 2017
-
Abstract
- Cardiac arrhythmias associated with intracellular calcium inhomeostasis are refractory to antiarrhythmic therapy. We hypothesized that late sodium current (I <subscript>Na</subscript> ) contributed to the calcium-related arrhythmias. Monophasic action potential duration at 90% completion of repolarization (MAPD <subscript>90</subscript> ) was significantly increased and ventricular arrhythmias were observed in hearts with increased intracellular calcium concentration ([Ca <superscript>2+</superscript> ] <subscript>i</subscript> ) by using Bay K 8644, and the increase became greater in hearts treated with a combination of ATX-II and Bay K 8644 compared to Bay K 8644 alone. The prolongations caused by Bay K 8644 and frequent episodes of ventricular tachycardias, both in absence and presence of ATX-II, were significantly attenuated or abolished by late I <subscript>Na</subscript> inhibitors TTX and eleclazine. In rabbit ventricular myocytes, Bay K 8644 increased I <subscript>CaL</subscript> density, calcium transient and myocyte contraction. TTX and eleclazine decreased the amplitude of late I <subscript>Na</subscript> , the reverse use dependence of MAPD <subscript>90</subscript> at slower heart rate, and attenuated the increase of intracellular calcium transient and myocyte contraction. TTX diminished the phosphorylation of CaMKII-δ and Na <subscript>v</subscript> 1.5 in hearts treated with Bay K 8644 and ATX-II. In conclusion, late I <subscript>Na</subscript> contributes to ventricular arrhythmias and its inhibition is plausible to treat arrhythmias in hearts with increased [Ca <superscript>2+</superscript> ] <subscript>i</subscript> .
- Subjects :
- Animals
Arrhythmias, Cardiac physiopathology
Disease Models, Animal
Male
Muscle Contraction drug effects
Oxazepines pharmacology
Phosphorylation
Rabbits
Tetrodotoxin pharmacology
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester pharmacology
Arrhythmias, Cardiac metabolism
Calcium metabolism
Calcium Channel Agonists pharmacology
Calcium-Calmodulin-Dependent Protein Kinase Type 2 metabolism
Sodium Channels metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 2045-2322
- Volume :
- 7
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Scientific reports
- Publication Type :
- Academic Journal
- Accession number :
- 28428622
- Full Text :
- https://doi.org/10.1038/s41598-017-01056-0